Characterization of class 1 integrons and antimicrobial resistance in CTX-M-3-producing Serratia marcescens isolates from Southern Taiwan

Japanese Journal of Infectious Diseases

Volumn 60, Issue 5, 2007, Pages 250-256

  Peng, Chien Fang ^a,b   Lee, Mei Feng ^a   Fu, Hsiao Ting ^a   Chen, Yuh Jyh ^a   Hsu, Hui Jine ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE CTX M 3; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; KANAMYCIN; PIPERACILLIN; SPECTINOMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

AMPLICON; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENZYME SYNTHESIS; GENE AMPLIFICATION; GENE CASSETTE; GENE TRANSFER; HUMAN; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; SERRATIA MARCESCENS; TAIWAN;

BASE SEQUENCE; BETA-LACTAMASES; CONJUGATION, GENETIC; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTEGRONS; PHYLOGENY; POLYMERASE CHAIN REACTION; SERRATIA INFECTIONS; SERRATIA MARCESCENS; TAIWAN;

EID: 34948831099     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hejazi, A. and Falkiner, F.R. (1997): Serratia marcescens. J. Med. Microbiol., 46, 903-912.
2. Yu, W.L., Lin, C.W. and Wang, D.Y. (1998): Serratia marcescens bacteremia. clinical features and antimicrobial susceptibilities of the isolates. J. Microbiol. Immunol. Infect., 31, 171-179.
3. Shih, H.I., Lee, H.C., Lee, N.Y., et al. (2005): Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance. J. Microbiol. Immunol. Infect., 38, 350-357.
4. Byrne, A.H., Boyle, B., Herra, C.M., et al. (2000): Serratia marcescens causing hospital-acquired lower respiratory tract infection. J. Hosp. Infect., 45, 242-244.
5. Su, L.H., Ou, J.T., Leu, H.S., et al. (2003): Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens. J. Clin. Microbiol., 41, 4726-4732.
6. Lauderdale, T.L., McDonald, L.C., Shiau, Y.R., et al. (2004): The status of antimicrobial resistance in Taiwan among gram-negative pathogens. the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000. Diagn. Microbiol. Infect. Dis., 48, 211-219.
7. Bagattini, M., Crispino, M., Gentile, F., et al. (2004): A nosocomial outbreak of Serratia marcescens producing inducible Amp C-type beta-lactamase enzyme and carrying antimicrobial resistance genes within a class 1 integron. J. Hosp. Infect., 56, 29-36.
8. Cheng, K.C., Chuang, Y.C., Wu, L.T., et al. (2006): Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan. Jpn. J. Infect. Dis., 59, 147-152.
9. Nakamura, T., Shibata, N., Doi, Y., et al. (2002): IMP-1 type metalo-beta-lactamase producing Serratia marcescens strains isolated from blood culture between 1991 to 2000. J. Jpn. Assoc. Infect. Dis., 76, 246-253 (in Japanese).
10. Bonnet, R. (2004): Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother., 48, 1-14.
11. Wu, L.T., Tsou, M.F., Wu, H.J., et al. (2004): Survey of CTX-M-3 extended-spectrum beta-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan. Diagn. Microbiol. Infect. Dis., 49, 125-129.
12. Kim, J. and Lim, Y.M. (2005): Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrob. Agents Chemother., 49, 1572-1575.
13. Hall, R.M. and Collis, C.M. (1995): Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol. Microbiol., 15, 593-600.
14. Falbo, V., Carattolli, A., Tosini, F., et al. (1999): Antibiotic resistance conferred by a conjugative plasmid and a class I integron in Vibrio cholerae O1 El Tor Strains Isolated in Albania and Italy. Antimicrob. Agents Chemother., 43, 693-696.
15. Yum, J.H., Yong D., Lee, K., et al. (2002): A new integron carrying VIM-2 metallo-β-lactamase gene cassette in a Serratia marcescens isolate. Diagn. Microbiol. Infect. Dis., 42, 217-219.
16. Centron, D. and Roy, P.H. (2002): Presence of a group II intron in a multiresistant Serratia marcescens strain that harbors three integrons and a novel gene fusion. Antimicrob. Agents Chemother., 46, 1402-1409.
17. National Committee for Clinical Laboratory Standards (2005): Performance standards for antimicrobial susceptibility testing; 15th informational supplement (M100-S15). National Committee for Clinical Laboratory Standards, Wayne, Pa., USA.
18. Dutour, C., Bonnet, R., Marchandin, H., et al. (2002): CTX-M-1, CTX-M-3, and CTX-M-14 beta-lactamases from Enterobacteriaceae isolated in France. Antimicrob. Agents Chemother., 46, 534-537.
19. Altschul, S.F., Gish, W., Miller, W., et al. (1990): Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
20. National Committee for Clinical Laboratory Standards (2003): Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A8. National Committee for Clinical Laboratory Standards, Wayne, Pa., USA.
21. Baker, C.N., Stocker, S.A., Culver, D.H., et al. (1991): Comparison of the E test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J. Clin. Microbiol., 29, 533-538.
22. Kado, C.I. and Liu, S.-T. (1981): Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol., 145, 1365-1373.
23. Taylor, D.E., De Grandis, S.A., Karmali, M.A., et al. (1981): Transmissible plasmids from Campylobacter jejuni. Antimicrob. Agents Chemother., 19, 831-835.
24. Sambrook, J.E., Fritsch, F. and Maniatis, T. (1989): Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., USA.
25. Versalovic, J., Koeuth, T. and Lupski, J.R. (1991): Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res., 19, 6823-6831.
26. Shibata, N., Doi, Y., Yamane, K., et al. (2003): PCR typing of genetic determinants for metallo-beta lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol., 41, 5407-5413.
27. Hsu, S.C., Chiu, T.H., Pang, J.C., et al. (2006): Characterisation of anti-microbial resistance patterns and class 1 integrons among Escherichia coli and Salmonella enterica serovar Choleraesuis strains isolated from humans and swine in Taiwan. Int. J. Antimicrob. Agents, 27, 383-391.
28. Su, J., Shi, L., Yang, L., et al. (2006): Analysis of integrons in clinical isolates of Escherichia coli in China during the last six years. FEMS Microbiol. Lett., 54, 75-80.
29. Kang, H.Y., Jeong, Y.S., Oh, J.Y., et al. (2005): Characterization of anti-microbial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea. J. Antimicrob. Chemother., 55, 639-644.
30. Zhang, H., Shi, L., Li, L., et al. (2004): Identification and characterization of class 1 integron resistance gene cassettes among Salmonella strains isolated from healthy humans in China. Microbiol. Immunol., 48, 639-645.
31. Mazel, D. (2006): Integrons: agents of bacterial evolution. Nat. Rev. Microbiol., 4, 608-620.
32. Bouza, E., Garcia de la Torre, M., Erica, A., et al. (1987): Serratia bacteremia. Diagn. Microbiol. Infect. Dis., 7, 237-247.
33. Docic, M. and Bilkei, G. (2003): Differences in antibiotic resistance in Escherichia coli, isolated from East-European swine herds with or without prophylactic use of antibiotics. J. Vet. Med. B Infect. Dis. Vet. Public Health, 50, 27-30.
34. Kim, T.-E., Kwon, H.-J., Cho, S.-H., et al. (2007): Molecular differentiation of common promoters in Salmonella class 1 integrons. J. Microbiol. Methods, 68, 453-457.
35. Kang, S.G., Lee, D.Y., Shin, S.J., et al. (2005): Changes in patterns of antimicrobial susceptibility and class 1 integron carriage among Escherichia coli isolates. J. Vet. Sci., 6, 201-205.